首页> 外文期刊>BioMed research international >Heat Shock Protein 72 Expressing Stress in Sepsis; Unbridgeable Gap between Animal and Human Studies-A Hypothetical 'Comparative' Study
【24h】

Heat Shock Protein 72 Expressing Stress in Sepsis; Unbridgeable Gap between Animal and Human Studies-A Hypothetical 'Comparative' Study

机译:热休克蛋白72在脓毒症中表达应激;动物与人类研究之间的不可逾越的鸿沟-一项假设性的“比较”研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Heat shock protein 72 (Hsp72) exhibits a protective role during times of increased risk of pathogenic challenge and/or tissue damage. The aim of the study was to ascertain Hsp72 protective effect differences between animal and human studies in sepsis using a hypothetical "comparative study" model. Forty-one in vivo (56.1%), in vitro (17.1%), or combined (26.8%) animal and 14 in vivo (2) or in vitro (12) human Hsp72 studies (P < 0.0001) were enrolled in the analysis. Of the 14 human studies, 50% showed a protective Hsp72 effect compared to 95.8% protection shown in septic animal studies (P < 0.0001). Only human studies reported Hsp72-associated mortality (21.4%) or infection (7.1%) or reported results (14.3%) to be nonprotective (P < 0.001). In animal models, any Hsp72 induction method tried increased intracellular Hsp72 (100%), compared to 57.1% of human studies (P < 0.02), reduced proinflammatory cytokines (28/29), and enhanced survival (18/18). Animal studies show a clear Hsp72 protective effect in sepsis. Human studies are inconclusive, showing either protection or a possible relation to mortality and infections. This might be due to the fact that using evermore purified target cell populations in animal models, a lot of clinical information regarding the net response that occurs in sepsis is missing.
机译:热休克蛋白72(Hsp72)在致病性攻击和/或组织损伤的风险增加期间表现出保护作用。该研究的目的是使用一种假设的“比较研究”模型来确定败血症动物研究和人类研究之间的Hsp72保护作用差异。将41例体内Hsp72研究(P <0.0001)纳入了体内(56.1%),体外(17.1%)或动物组合(26.8%)和14体内(2)或体外(12)人Hsp72研究(P <0.0001) 。在14项人体研究中,有50%的人表现出Hsp72的保护作用,而在败血性动物研究中则有95.8%的表现(P <0.0001)。仅人类研究报告Hsp72相关死亡率(21.4%)或感染(7.1%)或报告结果(14.3%)为非保护性(P <0.001)。在动物模型中,任何Hsp72诱导方法都尝试增加细胞内Hsp72(100%),而人类研究的比例为57.1%(P <0.02),促炎细胞因子减少(28/29)和存活率提高(18/18)。动物研究表明,Hsp72在脓毒症中具有明显的保护作用。人体研究尚无定论,它显示出保护作用或与死亡率和感染的可能关系。这可能是由于这样的事实,即在动物模型中使用了越来越多的纯化靶细胞群,有关败血症中发生的净反应的许多临床信息都丢失了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号